Evidence map›Paper›PMID 39144809›Full record

ArticleACS energy letters2024

Direct Anchoring of Molybdenum Sulfide Molecular Catalysts on Antimony Selenide Photocathodes for Solar Hydrogen Production.

Pardis Adams, Jan Bühler, Iva Walz, Thomas Moehl, Helena Roithmeyer, Olivier Blacque, Nicolò Comini, J Trey Diulus, Roger Alberto, Sebastian Siol and 3 more

Abstract read
In one paragraph

Article in ACS energy letters, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Pardis AdamsDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.
Jan BühlerDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.ORCID https://orcid.org/0000-0002-6096-6531
Iva WalzDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.
Thomas MoehlDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.
Helena RoithmeyerDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.ORCID https://orcid.org/0000-0002-6585-5953
Olivier BlacqueDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.
Nicolò CominiDepartment of Physics, University of Zurich, Zurich, 8057, Switzerland.
J Trey DiulusDepartment of Physics, University of Zurich, Zurich, 8057, Switzerland.
Roger AlbertoDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.ORCID https://orcid.org/0000-0001-5978-3394
Sebastian SiolSurface Science and Coating Technologies Laboratory/Transport at Nanoscale Interfaces Laboratory, Swiss Federal Laboratories for Materials Science and Technology (EMPA), Dübendorf, 8600, Switzerland.ORCID https://orcid.org/0000-0002-0907-6525
Mirjana DimitrievskaSurface Science and Coating Technologies Laboratory/Transport at Nanoscale Interfaces Laboratory, Swiss Federal Laboratories for Materials Science and Technology (EMPA), Dübendorf, 8600, Switzerland.ORCID https://orcid.org/0000-0002-9439-1019
Zbynek NovotnyDepartment of Physics, University of Zurich, Zurich, 8057, Switzerland.
S David TilleyDepartment of Chemistry, University of Zurich, Zurich, 8057, Switzerland.ORCID https://orcid.org/0000-0002-7542-1147

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Molybdenum sulfide serves as an effective nonprecious metal catalyst for hydrogen evolution, primarily active at edge sites with unsaturated molybdenum sites or terminal disulfides. To improve the activity at a low loading density, two molybdenum sulfide clusters, [Mo

Identifiers

PMID39144809
PMCPMC11320643

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.